Stocks
Dicerna Pharmaceuticals (DRNA) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.78 | 1.92 | 3.46 | 2.73 | 4.68 | 4.23 | |||
| Changes by years, y/y, % | -49% | +145% | +80% | -21% | +71% | +25.1% | |||
Dicerna Pharmaceuticals. Debt/EBITDA
Dicerna Pharmaceuticals. Debt/EBITDA, changes, %
Dicerna Pharmaceuticals (DRNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| Debt/EBITDA | 5.17 | 4.67 | 4.19 | 4.22 | 4.23 | 4.23 | ||
| Changes by years, y/y, % | +63% | +71% | -29% | -20% | -18% | |||
| Changes by quarters, q/q, % | -2% | -10% | -10% | +1% | +0% | |||
